[1] Wang J,Feng L,Zhu Z,et al.Aquaporins as diagnostic and therapeutic targets in cancer:How far we are[J]?J Transl Med,2015,13(1):1-11.
[2] Ribatti D,Ranieri G,Annese T,et al.Aquaporins in cancer[J].Biochim Biophys Acta,2014,1840(5):1550-1553.
[3] Tradtrantip L,Jin BJ,Yao X,et al.Aquaporin-targeted therapeutics:State-of-the-field [J].Adv Exp Med Biol,2017,969:239-250.
[4] Zhao JH,Tang JH.Basic breast research and precision medicine[J].Chinese Journal of Cancer Surgery,2015,7(03):146-149.[赵建华,唐金海.乳腺癌基础研究与精准医学[J].中国肿瘤外科杂志,2015,7(03):146-149.]
[5] Verkman AS,Smith AJ,Phuan PW,et al.The aquaporin-4 water channel as a potential drug target in neurological disorders [J].Expert Opin Ther Targets,2017,21(12):1161-1170.
[6] Shi Z,Zhang T,Luo L,et al.Aquaporins in human breast cancer:identification and involvement in carcinogenesis of breast cancer[J].J Surg Oncol,2012,106(3):267-272.
[7] Liu L,Miao L,Liu Y,et al.S100A11 regulates renal carcinoma cell proliferation,invasion,and migration via the EGFR/Akt signaling pathway and E-cadherin[J].Tumour Biol,2017,39(5):1-8.
[8] Wong SHM,Fang CM,Chuah LH,et al.E-cadherin:Its dysregulation in carcinogenesis and clinical implications[J].Crit Rev Oncol Hematol,2018,1(121):11-22.
[9] Lisa Mohamet,Kate Hawkins,Christopher M.et al.Loss of function of E-cadherin in embryonic stem cells and the relevance to models of tumorigenesis [J].J Oncol,2011,2011:352616.
[10] Kim KH,Kim JY,Kwak JH,et al.Different apoptotic effects of saxifragifolin C in human breast cancer cells[J].Arch Pharm Res,2016,39(4):577-589.
[11] Wu B,Zhang F,Yu M,et al.Up-regulation of Anxa2 gene promotes proliferation and invasion of breast cancer MCF-7 cells[J].Cell Prolif,2012,45(3):189-198.
[12] Fujii S,Tokita K,Wada N,et al.MEK-ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes[J].Oncogene,2011,30(39):4118-4128.
[13] Musch A.From a common progenitor to distinct liver epithelial phenotypes[J].Curr Opin Cell Biol,2018,2(54):18-23.
[14] Chaw SY,Abdul Majeed A,Dalley AJ,et al.Epithelial to mesenchymal transition (EMT) biomarkers-E-cadherin,beta-catenin,APC and Vimentin-in oral squamous cell carcinogenesis and transformation[J].Oral Oncol,2012,48(10):997-1006.
[15] Rao A,Herr DR.G protein-coupled receptor GPR19 regulates E-cadherin expression and invasion of breastcancer cells[J].Biochim Biophys Acta,2017,1864(7):1318-1327.
[16] You K,Su F,Liu L,et al.SCARA5 plays a critical role in the progression and metastasis of breast cancer by inactivating the ERK1/2,STAT3,and AKT signaling pathways[J].Mol Cell Biochem,2017,435(1-2):47-58.